Completed PHASE4 INTERVENTIONAL 2-arm NCT01835379

Study of Oasis Ultra in Diabetic Foot Ulcers

A Randomized, Open Label Controlled Trial of OASIS® Ultra Tri-Layer Matrix Compared to Standard Care in the Healing of Diabetic Foot Ulcers

Sponsor: Healthpoint

Conditions Diabetic Foot Ulcer

Interventions Oasis Standard

Updated 8 times since 2017 Last updated: Jan 20, 2015 Started: May 31, 2013 Primary completion: Sep 30, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Diabetic Foot Ulcer and is currently completed. Healthpoint leads this study, which shows 8 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Healthpoint

Data source: Healthpoint

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bayonne, United States , Carlsbad, United States , Dallas, United States , Evansville, United States , Fair Oaks, United States , Fort Worth, United States , Fresno, United States , Houston, United States , Little Rock, United States , Madisonville, United States and 5 more locations